GeneralNewsBrief

Reply to the Letter to the Editor: Prognostic value of imaging-detected immune-related adverse events in biliary tract c

European radiologyyesterday

Reply to the Letter to the Editor: Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy.

Read the source

Also covered by

Letter to the Editor: Prognostic value of imaging-detected immune-related adverse events in biliary tract cancer patients receiving durvalumab-based chemotherapy. · European radiology

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.